[California Life Sciences' Spring Innovation Showcase]

[Pharmasaga participate in Bio+Health Track Dinner]

[Pharmasaga participate in SkyDeck x ITRI : Innovation, investment and Global Startup Growth]

[Pharmasaga participate in ITRI : Pitch and Investor Meetup]

[Pharmasaga participate in Berkeley SkyDeck Pitch Day]

A monumental milestone for Pharmasaga (7878.TW) as we advance into the global diabetes treatment market! We are thrilled to announce that we have officially received the prestigious TREE Program subsidy grant from the Department of Industrial Technology, MoEA.

By Reporter 吳典叡 / Comprehensive Report

[Link to Award Recipient List]

The US BIO International Convention is a major global event on the global biotechnology and pharmaceutical sector calendar, bringing together top pharmaceutical companies, biotech startups, and investors from around the world. The convention offers extensive opportunities for business collaboration, particularly in licensing, technology transfer,...

Pharmasaga officially initiated its Phase I clinical trial in December 2023, following dual approval from the Taiwan Food and Drug Administration (TFDA) and the U.S. Food and Drug Administration (USFDA).